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到 FCBA 技术中，以提高检测的灵敏度。 












针进行偶联，在与其互补的环状锁式探针、dNTP 及 phi29 DNA 聚合酶的作用下
进行滚环扩增，并通过与荧光素标记的检测探针杂交使检测信号得到有效放大。

















进行了考察，结果表明体系对人 PSA、CEA 和 AFP 的动态检测范围分别为 0.5 
pg/mL~100 ng/mL、2 pg/mL~500 ng/mL 和 0.05 pg/mL~ 200 ng/mL， 低检测限
分别为 0.29 pg/mL、1.61 pg/mL 和 0.034 pg/mL，检测灵敏度与传统方法相比提
高了三个数量级，对临床血清样本的检测重现性良好。 
 

















  Effective detection of tumor markers plays an important role in early diagnosis, 
treatment evaluation and recurrence prediction of malignant tumors. However, in the 
application process, single biomarker detection faces some shortcomings such as 
insufficient specificity and low positive rate. Therefore, it is urgent to enhance the 
accuracy of tumor diagnosis by measuring a panel of tumor markers at the same time. 
Flow cytomitric bead array (FCBA), also named as suspension array, is a novel 
diagnostic platform which uses encoded microbeads coupled with biological probes to 
capture the analytes in micro-volume of sample for qualitative and quantitative 
analysis with flow cytometry. As flow cytometric bead array undergoes in liquid 
phase, it has greater flexibility, faster binding kinetics, higher reproducibility and 
wider detection range than microarray. Unfortunately, the concentration of some 
important biomarkers in body fluids is too low to be detected by the conventional 
suspension array. To overcome this problem, we introduce an amplification strategy 
into FCBA technology to improve the analytical sensitivity. 
  Rolling circle amplification (RCA) has been widely used for the sensitive detection 
of proteins as an efficient signal amplification strategy. RCA is an isothermal 
amplification process mediated by phi29 DNA polymerases in which long single 
stranded (ss) DNA molecules are synthesized on a short circular ssDNA template 
(named padlock probe) by using a single DNA primer. It possesses great sensitivity 
and sequence specificity. Compared with PCR amplification technology, the 
isothermal amplification of RCA can keep the immunoactivity of antigens and 
antibodies while enhancing the signals at the same time.  
For the purpose of sensitive multiplex detection of low-aboundence biomarkers, in 
this research, an ultra-sensitive method for multiplex detection of three tumor markers 
(PSA, CEA and AFP) is proposed by the combination of FCBA with RCA technology. 
















ensure the equal detection sensitivity of non-RCA suspension array and traditional 
array. After the successful synthesis and purification of circular padlock probe, we 
built up a one-component immuno-RCA suspension array. A standard sandwich 
format is adopted where antigen-specific capture antibodies are immobilized on the 
beads, specimen containing the antigen proteins are then added and allowed to bind 
onto the beads. The bead-captured antigens are subsequently recognized by the 
reporter antibody-primer conjugate. At the presence of circular padlock probe, dNTP 
and phi29 polymerase, the primer is extended, producing a long single stranded DNA 
molecule consisting of tandem repeats of the template. The amplification product 
remains attached to the beads and is fluorescently labeled by hybridization with FITC 
labeled detection probe. Finally, a three-component immuno-RCA flow cytometric 
size-coded bead array for the simultaneous detection of AFP, PSA and CEA is 
developed. Under the optimized conditions, the detection ranges for PSA, CEA and 
AFP are 0.5 pg/mL~100 ng/mL, 2 pg/mL~500 ng/mL and 0.05 pg/mL~200 ng/mL, 
respectively, with detection limits of 0.29 pg/mL, 1.61 pg/mL and 0.034 pg/mL, 
respectively. The detection sensitivity is improved three orders of magnitude on 
average. Tests on clinical sera have been proved with great reproducibility.  
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的肿瘤标志物 (tumor marker) 始终是人们关注的焦点。肿瘤标志物是指在恶性
肿瘤的发生和增殖过程中，由肿瘤细胞的基因表达合成或由机体对肿瘤反应而异
常产生或异常表达的、反映肿瘤存在和生长的一类物质，存在于病人的血液、体
液、细胞或组织中[3]。从 1846 年 Benee-Jones 发现本周蛋白可作为多发性骨髓瘤
的实验室诊断依据以来，对肿瘤标志物的研究已有一百多年的历史，但直到 1963
年 Abelev 发现甲胎蛋白 (AFP)，1965 年 Gold 和 Freedman 发现癌胚抗原 (CEA) 




CEA) 、激素 (如 HCG) 、组织特异性抗原 (如 PSA) 、粘蛋白、糖蛋白、糖脂 (如
CA125) 、癌基因及其产物以及多胺类等；(2) 肿瘤与宿主相互作用后产生的，
包括：血清铁蛋白、免疫复合物、急性时相蛋白、白细胞介素受体、肿瘤坏死因











































微珠阵列技术 早可追溯到 1956 年，Singer 和 Plotz 首次以胶乳颗粒为载体



























图 1.1 流式微珠免疫阵列技术检测流程图 
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